Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.
about
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infectionLessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial.Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.
P2860
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of cytomegalo ...... ers of inflammation in plasma.
@ast
Characterization of cytomegalo ...... ers of inflammation in plasma.
@en
Characterization of cytomegalo ...... ers of inflammation in plasma.
@nl
type
label
Characterization of cytomegalo ...... ers of inflammation in plasma.
@ast
Characterization of cytomegalo ...... ers of inflammation in plasma.
@en
Characterization of cytomegalo ...... ers of inflammation in plasma.
@nl
prefLabel
Characterization of cytomegalo ...... ers of inflammation in plasma.
@ast
Characterization of cytomegalo ...... ers of inflammation in plasma.
@en
Characterization of cytomegalo ...... ers of inflammation in plasma.
@nl
P2093
P2860
P50
P1433
P1476
Characterization of cytomegalo ...... ers of inflammation in plasma.
@en
P2093
Anders Asberg
Anders Hartmann
Angelo A Bignamini
Atul Humar
Halvor Rollag
Mark D Pescovitz
P2860
P304
P356
10.1371/JOURNAL.PONE.0060767
P407
P577
2013-04-08T00:00:00Z